Asian Spectator

Men's Weekly

.

Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

  • Written by PR Newswire Asia - Asian Spectator
Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

SYDNEY, Feb. 19, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the United States (US) Food and Drug Administration (FDA)...

Magazine

Female genital cutting: why Southeast Asia should follow Africa’s lead in challenging religious and cultural justifications

Illustration of campaign against Female Genital Mutilation (FGM).Tunatura/ShutterstockFemale genital mutilation or cutting (FGM/C) remains a threat to the rights of women in Southeast Asia, often reli...

Manfaat tempe juga bisa menyehatkan tulang: Mengapa pengakuan dari UNESCO saja tidak cukup?

● Sejumlah negara (seperti Belgia dan Jepang) merekomendasikan warganya memperbanyak konsumsi tempe. ● Tempe punya banyak manfaat kesehatan, termasuk bagi kesehatan tulang.● Pemerint...

Pemberdayaan warga jadi solusi efektif meredam abrasi: Pelajaran dari pesisir Bulukumba

● Indonesia memiliki banyak kawasan pesisir rawan abrasi ekstrem, seperti di Bulukumba, Sulawesi Selatan.● Pemberdayaan masyarakat setempat amat krusial untuk mencegah abrasi.● Pemba...